Dr. Guy Aaron Young, MD

Dr. Young practices at Children's Hospital Los Angeles in Los Angeles, California, part of Children's Hospital Los Angeles.

Dr. Young's NPI, 1629175195, was assigned on September 19, 2006. Dr. Young graduated from Renaissance School of Medicine at Stony Brook University in 1992. Dr. Young holds California license G85188.

Dr. Young's primary practice is Children's Hospital Los Angeles, at 4650 Sunset Blvd, MS 108, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (323) 669-2164.

Dr. Young's primary practice is Children's Hospital Los Angeles in Los Angeles, California, part of Children's Hospital Los Angeles. The medical group on file is Children's Hospital Los Angeles Medical Group. Dmand AI also links Dr. Young to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Young practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatric hematology-oncology is Dr. Young's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Young is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Young's licenses on file in 6 states: California, Montana, Florida, Virginia, Maryland and District of Columbia.

Across all payers, Dmand AI patient panel data puts Dr. Young's median patient age at 15, with 48% women.

In 2020, Dr. Young wrote 14 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $508 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Young for performance year 2024, reported as part of a group. Dr. Young accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 123 papers to Dr. Young, published from 2014 to 2025. 2023 was the busiest year, with 15. The most frequent topics are Hemophilia A, Hemorrhage and Factor VIII. Dr. Young has published most often in Haemophilia. Dr. Young's most frequent co-authors are Steven W. Pipe, MD, Julie Ann Jaffray, MD and Brian R. Branchford, MD.

Dmand AI links Dr. Young to 6 clinical trials, 2 of them phase 4 studies. 2 are still active or recruiting. Conditions studied include Hemophilia A, Coagulation Protein Disorders and Hemophilia B. Children's Hospital Los Angeles sponsors the most, 2. Open Payments lists research payments to Dr. Young that name 4 trials.

CMS Open Payments shows 2,019 general payments to Dr. Young from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Sanofi and Genzyme US Companies paid the most, $825,151. It also lists 46 research payments totaling $47,494 from 2018 to 2025, naming 4 clinical trials.

Dmand AI lists 1 award for Dr. Young, most recently Physician of the Year in 2013.

Dr. Young graduated from Renaissance School of Medicine at Stony Brook University in 1992. Dr. Young is a member of ASH and International Society on Thrombosis and Haemostasis.

Dr. Young is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.